Alopecia Treatment Market to Surpass US$ 11.2 Billion by 2026 - Coherent Market Insights

Published On : Jul 18, 2019

Global Alopecia Treatment Market, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 7,325.0 million in 2017, and is projected to exhibit a CAGR of 4.9% over the forecast period (2018–2026), as highlighted in a new report published by Coherent Market Insights.

Increasing product approvals and product launches by market players is expected to augment the market growth

Key players in the market are focused on product launches and product approvals, in order to develop novel products to address critical unmet needs of patients. For instance, in July 2018, Aclaris Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) grant as the Fast Track designation to Aclaris’ investigational topical Janus Kinase (JAK) 1/3 inhibitor (ATI-502) for the treatment of alopecia areata, including patchy alopecia areata and variants of the disease, alopecia totalis and universalis.

Moreover, robust pipeline is expected launch advanced drugs for alopecia in the near future which can boost the market growth. For instance, in June 2018, Almirall, a company based in Spain, published the results of Phase III trial of ALM12845/P-3074 for androgenic alopecia. The company is planning for the regulatory filing of the drug in the E.U. by the end of 2019.

Browse 31 Market Data Tables and 25 Figures spread through 193 Pages and in-depth TOC on ‘Alopecia Treatment Market’- Global Forecast to 2026, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the global alopecia treatment market, click the link below:

https://www.coherentmarketinsights.com/market-insight/alopecia-treatment-market-1847

Furthermore, increasing use of chemotherapy and radiation therapy for treatment of cancer, induces alopecia, which is expected to drive the global alopecia treatment market growth. According to the study published in National Center for Biotechnology Information (NCBI), February 2017, incidence of alopecia associated with chemotherapy drug categories such as topoisomerase inhibitors causes around 60% to 100 % alopecia, Anti microtubule agents caused around 80% alopecia.

Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance, in 2017, Aclaris Therapeutics, Inc. acquired Confluence Life Sciences, Inc., a company focused on discovery and development of kinase inhibitors to treat autoimmune disorders such as alopecia areata, vitiligo, atopic dermatitis, and others.

Key Takeaways of the Global Alopecia Treatment Market:

  • The global alopecia treatment market is expected to exhibit a CAGR of 4.9% over the forecast period, owing to increasing prevalence of alopecia. According to Orphanet Report, in January 2019, the prevalence of Alopecia Universalis was around 25/100,000 and Alopecia Totalis was around 10.5/ 100,000 in the European population.
  • Among disease type, the androgenic alopecia segment held a dominant position in the global alopecia treatment market in 2018, owing to increasing cases of androgenic alopecia and increasing ongoing clinical trials. F0r instance, in March 2019, Assiut University initiated clinical trial to study the role and efficacy of Vitamin D in treatment of androgenic alopecia. The study is expected to complete in December 2019.
  • Among drug type, the topical agents segment held a dominant position in the global alopecia treatment market in 2018, owing to increasing number of drug candidates in the category of topical agents. For instance, in May 2018, Energenesis Biomedical Co., Ltd., in collaboration with A2 Healthcare Taiwan Corporation, initiated phase 2 clinical trial to evaluate the efficacy and safety of ENERGI-F701 solution for topical use in female pattern baldness. The study was completed in March 2019.
  • Key players operating in the global alopecia treatment market include Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Merck & Co., Inc., Daiichi Sankyo Company, Limited, and Sun Pharmaceutical Industries Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.